Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02839174 · ClinicalTrials.gov registry record
Type One Diabetes and Low Carb Study
A clinical trial, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 340
- Enrollment target
NCT02839174: Completed study, sponsored by Boston Children's Hospital.
NCT02839174 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 340 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02839174 has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 340 participants
- Enrollment target
Study Summary
The investigators have identified a support group on social media with \~1500 members (children and adults), the majority of whom have T1DM and follow a carbohydrate-restricted diet. Many participants report exceptionally low HbA1C and insulin requirements. If these anecdotal reports are reflective of a large group of people with type 1 diabetes, a clinical trial would be warranted. The investigators propose to survey the above-mentioned group and their professional diabetes care providers to characterize glycemic control and explore associated dietary and diabetes care factors.
Primary Outcome
self reported, confirmed by professional diabetes care provider if possible
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 340 participants |
| Start Date | 2016-09 |
| Est. Completion | 2017-03 |
What the finished NCT02839174 record still lists
NCT02839174 is an observational study that tracks outcomes without assigning an intervention. The registered 340 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02839174 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02839174 about?
NCT02839174 is a clinical study titled "Type One Diabetes and Low Carb Study". The investigators have identified a support group on social media with \~1500 members (children and adults), the majority of whom have T1DM and follow a carbohydrate-restricted diet. Many participants report exceptionally low HbA1C and insulin requirements. If these anecdotal reports are reflective ...
What is the current status of trial NCT02839174?
This trial is currently completed. The enrollment target is 340 participants. The study started on 2016-09. Estimated completion is 2017-03.
Who is sponsoring clinical trial NCT02839174?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04176172 · 340 participants · Phase 3
Optimizing Tobacco Use Treatment for PLWHA
- NCT04545424 · 340 participants · Phase 2
Trial of Therapeutic Hypothermia in Patients With ARDS
- NCT04806958 · 340 participants · NA
The PulsePoint Study
- NCT05323409 · 340 participants · NA
Improving Comprehensive Care of Cancer Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia